BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30985701)

  • 21. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
    Nunes T; Etchevers MJ; Sandi MJ; Pinó Donnay S; Grandjean T; Pellisé M; Panés J; Ricart E; Iovanna JL; Dagorn JC; Chamaillard M; Sans M
    PLoS One; 2014; 9(1):e84957. PubMed ID: 24416322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
    Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Pinto-Lopes P; Afonso J; Pinto-Lopes R; Rocha C; Lago P; Gonçalves R; Tavares De Sousa H; Macedo G; Camila Dias C; Magro F
    Inflamm Bowel Dis; 2020 Oct; 26(11):1707-1719. PubMed ID: 31912883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population.
    Frigstad SO; Høivik M; Jahnsen J; Dahl SR; Cvancarova M; Grimstad T; Berset IP; Huppertz-Hauss G; Hovde Ø; Torp R; Bernklev T; Moum B; Jelsness-Jørgensen LP
    Scand J Gastroenterol; 2017 Jan; 52(1):100-106. PubMed ID: 27603182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Siva S; Rubin DT; Gulotta G; Wroblewski K; Pekow J
    Inflamm Bowel Dis; 2017 Jan; 23(1):152-157. PubMed ID: 27930412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Syed S; Michalski ES; Tangpricha V; Chesdachai S; Kumar A; Prince J; Ziegler TR; Suchdev PS; Kugathasan S
    Inflamm Bowel Dis; 2017 Sep; 23(9):1650-1658. PubMed ID: 28700535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INFLIXIMAB AND ADALIMUMAB SERUM TROUGH CONCENTRATIONS THRESHOLD ASSOCIATED WITH DEEP REMISSION IN INFLAMMATORY BOWEL DISEASE.
    Pascual-Marmaneu Ó; Belles-Medall MD; Ferrando-Piqueres R; Almela-Notari P; Mendoza-Aguilera M; Álvarez-Martín T
    Farm Hosp; 2021 Aug; 45(5):225-233. PubMed ID: 34806581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients.
    Frigstad SO; Høivik ML; Jahnsen J; Cvancarova M; Grimstad T; Berset IP; Huppertz-Hauss G; Hovde Ø; Bernklev T; Moum B; Jelsness-Jørgensen LP
    World J Gastroenterol; 2018 Aug; 24(29):3293-3301. PubMed ID: 30090009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.
    Kabbani TA; Koutroubakis IE; Schoen RE; Ramos-Rivers C; Shah N; Swoger J; Regueiro M; Barrie A; Schwartz M; Hashash JG; Baidoo L; Dunn MA; Binion DG
    Am J Gastroenterol; 2016 May; 111(5):712-9. PubMed ID: 26952579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum adipokines in inflammatory bowel disease.
    Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
    World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.
    Kalla R; Kennedy NA; Ventham NT; Boyapati RK; Adams AT; Nimmo ER; Visconti MR; Drummond H; Ho GT; Pattenden RJ; Wilson DC; Satsangi J
    Am J Gastroenterol; 2016 Dec; 111(12):1796-1805. PubMed ID: 27596694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Vitamin D with Inflammatory Bowel Disease Activity in Pediatric Patients.
    Kim S; Kang Y; Park S; Koh H; Kim S
    J Korean Med Sci; 2019 Aug; 34(32):e204. PubMed ID: 31432649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status.
    Ates Y; Degertekin B; Erdil A; Yaman H; Dagalp K
    Dig Dis Sci; 2008 Aug; 53(8):2215-21. PubMed ID: 18080768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.